2022
DOI: 10.1039/d2dt01085b
|View full text |Cite
|
Sign up to set email alerts
|

Stability of a half-sandwich Os(ii) complex with indomethacin-functionalized ligand in the presence of carboxypeptidase A

Abstract: In the presence of carboxypeptidase, the hydrolytically stable complex [Os(η6-pcym)(L2)Cl]PF6 (2) partially released the bioactive substituent indomethacin, bound through the amide bond to the chelating 2-(1,3,4-thiadiazol-2-yl)pyridine-based moiety of L2. Stability...

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 30 publications
0
1
0
Order By: Relevance
“…A similar strategy was applied for osmium(II) complex [Os(η 6 -pcym)Cl(L ind )]PF 6 ( Os ind ) containing the 2-(1,3,4-thiadiazol-2-yl)pyridine-based ligand bearing the cyclooxygenase inhibitor indomethacin (ind) [ 92 ]. This time, the bioactive substituent (i.e., ind) was bound to the carrier chelating ligand through the amide bond, which was cleaved exclusively in the presence of enzyme carboxypeptidase A (from bovine pancreases).…”
Section: Transition Metal Complexes For Cancer Therapymentioning
confidence: 99%
“…A similar strategy was applied for osmium(II) complex [Os(η 6 -pcym)Cl(L ind )]PF 6 ( Os ind ) containing the 2-(1,3,4-thiadiazol-2-yl)pyridine-based ligand bearing the cyclooxygenase inhibitor indomethacin (ind) [ 92 ]. This time, the bioactive substituent (i.e., ind) was bound to the carrier chelating ligand through the amide bond, which was cleaved exclusively in the presence of enzyme carboxypeptidase A (from bovine pancreases).…”
Section: Transition Metal Complexes For Cancer Therapymentioning
confidence: 99%